Scientific article
OA Policy
French

La greffe utérine en Suisse: les défis à venir

Published inRevue médicale suisse, vol. 16, no. 676-677, p. 42-46
Publication date2020-01-15
Abstract

Uterine transplant is a novel treatment option for women with absolute uterine infertility. Sixty uterine transplants have been performed worldwide to date. The first live birth happened in 2014 and since then 20 children have been born after this procedure. The procedure has several challenges: The donor is usually a woman alive. Surgery is long and complex for both the donor and the recipient, with a high risk of complications. Embryos have to be obtained through IVF. Pregnancies are at high risk for complications and require cesarean delivery, and transplant is temporary (the transplanted uterus is removed after pregnancy in order to allow discontinuation of immunosuppressive therapy). Uterine transplant is a new hope for women with absolute uterine infertility but a high-risk experimental procedure for the donor, the recipient and the newborns and raises major ethical questions.

Citation (ISO format)
BERKANE, Nadia et al. La greffe utérine en Suisse: les défis à venir. In: Revue médicale suisse, 2020, vol. 16, n° 676-677, p. 42–46.
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN1660-9379
284views
352downloads

Technical informations

Creation07/10/2021 07:35:00
First validation07/10/2021 07:35:00
Update16/03/2023 01:47:29
Status update16/03/2023 01:47:28
Last indexation31/10/2024 23:45:41
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack